0,1
"7.3.2.2	
Non-seminoma
Following first-line BEP only 6-10% of residual masses contain active cancer, 50% post-pubertal teratoma, 
and 40% necrotic-fibrotic tissue only [208]. Restaging patients following chemotherapy with FDG-PET is not 
indicated [50-52]. With complete radiological remission, RPLND is not indicated [209, 210].",
Recommendations,Strength rating
"Balance the individual patientsâ€™ potential benefits and risks of thromboprophylaxis during 
first-line chemotherapy in men with metastatic germ cell tumours.",Weak
"Avoid use of central venous-access devices during first-line chemotherapy whenever 
possible.",Weak
